Akoya Biosciences Inc - ESG Rating & Company Profile powered by AI
Jump to the end of the page for potential risks for Akoya Biosciences Inc based on industry, geography and marketcap. This webpage is a zero-cost Sustainability report for Akoya Biosciences Inc. Complete ESG assessment of Akoya Biosciences Inc are accessed by signing in.
Akoya Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.0; made up of an environmental score of 3.2, social score of 2.7 and governance score of 3.2.
3.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1309 | Willow Biosciences Inc | 3.1 | Medium |
1309 | biOasis Technologies Inc | 3.1 | Medium |
1336 | Akoya Biosciences Inc | 3.0 | Medium |
1336 | BridgeBio Pharma Inc | 3.0 | Medium |
1336 | Absci Corp | 3.0 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Akoya Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Does Akoya Biosciences Inc disclose current and historical energy intensity?
Does Akoya Biosciences Inc report the average age of the workforce?
Does Akoya Biosciences Inc reference operational or capital allocation in relation to climate change?
Does Akoya Biosciences Inc disclose its ethnicity pay gap?
Does Akoya Biosciences Inc disclose cybersecurity risks?
Does Akoya Biosciences Inc offer flexible work?
Does Akoya Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Akoya Biosciences Inc disclose the number of employees in R&D functions?
Does Akoya Biosciences Inc conduct supply chain audits?
Does Akoya Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Akoya Biosciences Inc conduct 360 degree staff reviews?
Does Akoya Biosciences Inc disclose the individual responsible for D&I?
Does Akoya Biosciences Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Akoya Biosciences Inc disclose current and / or historical scope 2 emissions?
Does Akoya Biosciences Inc disclose water use targets?
Does Akoya Biosciences Inc have careers partnerships with academic institutions?
Did Akoya Biosciences Inc have a product recall in the last two years?
Does Akoya Biosciences Inc disclose incidents of discrimination?
Does Akoya Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Has Akoya Biosciences Inc issued a profit warning in the past 24 months?
Does Akoya Biosciences Inc disclose parental leave metrics?
Does Akoya Biosciences Inc disclose climate scenario or pathway analysis?
Does Akoya Biosciences Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Akoya Biosciences Inc disclose the pay ratio of women to men?
Does Akoya Biosciences Inc support suppliers with sustainability related research and development?
Does Akoya Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Akoya Biosciences Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Akoya Biosciences Inc involved in embryonic stem cell research?
Does Akoya Biosciences Inc disclose GHG and Air Emissions intensity?
Does Akoya Biosciences Inc disclose its waste policy?
Does Akoya Biosciences Inc report according to TCFD requirements?
Does Akoya Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Akoya Biosciences Inc disclose energy use targets?
Does Akoya Biosciences Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Akoya Biosciences Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Akoya Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.